Case Study: Pulmonary thromboembolism in a patient after gastric cancer surgery
.svg)
Patients with cancer are four to seven times more likely to develop VTE than patients without cancer. The article highlights a case study of pulmonary thromboembolism after surgery for primary adenocarcinoma of the stomach. Caprini is the preferred VTE risk assessment model for surgical patients. Patients with cancer, especially those undergoing surgery for cancer, are at extremely high risk for developing VTE. The onset of pulmonary embolism (PE) can be divided into two phases, and, in general, the development of PE can be attributed to two factors, namely venous stasis and hypercoagulability. Comprehensive management of VTE in patients with cancer includes both the identification of patients who are most likely to benefit from pharmacological prophylaxis and the effective treatment to reduce the risk of VTE recurrence and mortality. The article highlights the thromboprophylaxis guideline recommendations for patients undergoing abdominopelvic surgery for cancer and the need for extended thromboprophylaxis.
